Efficacy and safety of microwave ablation for treatment of follicular thyroid neoplasms: a preliminary study.


Journal

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
ISSN: 1464-5157
Titre abrégé: Int J Hyperthermia
Pays: England
ID NLM: 8508395

Informations de publication

Date de publication:
2024
Historique:
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 8 9 2024
Statut: ppublish

Résumé

To assess the feasibility, efficacy, and safety of microwave ablation in treating follicular thyroid neoplasms and suspicious follicular thyroid neoplasms. In this retrospective study, the data of patients treated with microwave ablation for follicular neoplasms from December 2016 to January 2024 were summarized. The changes in nodule size, volume, technical success rate, disease progression, complete tumor resolution, thyroid function, and complications post-ablation were evaluated. Seventy-four patients (15 men, 59 women; mean age 46.3 ± 15.2 years) with follicular neoplasms were included. Over a median follow-up of 13 months, complete ablation was achieved, giving a 100% technical success rate. At the first month post-ablation, the maximum diameter of nodules showed no significant change ( Initial findings suggest microwave ablation is an effective and safe treatment for follicular neoplasms, with low incidences of disease progression and complications, while maintaining thyroid function.

Identifiants

pubmed: 39245445
doi: 10.1080/02656736.2024.2398558
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2398558

Auteurs

Xin-Yi Zhou (XY)

Beijing University of Chinese Medicine, Beijing, China.

Xin-Yu Yu (XY)

Zhongshan Medical School, Sun Yat-Sen University, Guangzhou, Guangdong, China.

Ying Wei (Y)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Zhen-Long Zhao (ZL)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Li-Li Peng (LL)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Yan Li (Y)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Jie Wu (J)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Shi-Liang Cao (SL)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Ming-An Yu (MA)

Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH